Free Trial

Nemaura Medical Q3 2024 Earnings Report

Nemaura Medical logo
$0.0002 +0.00 (+100.00%)
(As of 03:31 PM ET)

Nemaura Medical Earnings Headlines

Nemaura Medical Inc (NMRD)
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
NXNN Nexeon Medsystems Inc
See More Nemaura Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nemaura Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nemaura Medical and other key companies, straight to your email.

About Nemaura Medical

Nemaura Medical (NASDAQ:NMRD), a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

View Nemaura Medical Profile

More Earnings Resources from MarketBeat